Screening instruments for detecting illicit drug use/abuse that could be useful in general hospital wards: A systematic review

2011 ◽  
Vol 36 (12) ◽  
pp. 1111-1119 ◽  
Author(s):  
Noreen D. Mdege ◽  
Jenny Lang
Keyword(s):  
Systematic Review ◽  
Drug Use ◽  
General Hospital ◽  
Illicit Drug ◽  
Illicit Drug Use ◽  
Screening Instruments ◽  
Hospital Wards

scholarly journals PROTOCOL: 12‐step Programs for Reducing Illicit Drug Use: Protocol for a Systematic Review

2013 ◽  
Vol 9 (1) ◽  
pp. 1-46
Author(s):  
Mette Deding ◽  
Madina Saidj ◽  
Lars Brännström ◽  
Margaretha Järvinen ◽  
Anne‐Marie Klint Jørgensen ◽  
...  
Keyword(s):  
Systematic Review ◽  
Drug Use ◽  
Illicit Drug ◽  
Illicit Drug Use

Comorbidity of substance use and psychiatric disorders among inpatients of a General Hospital Psychiatric Unit

2011 ◽  
Vol 26 (S2) ◽  
pp. 85-85
Author(s):  
A. Pachi ◽  
K. Giotakis ◽  
T. Kostaras ◽  
A. Pavla ◽  
A. Christodoulaki ◽  
...  
Keyword(s):  
Substance Use ◽  
Drug Use ◽  
Psychiatric Disorders ◽  
General Hospital ◽  
Illicit Drug ◽  
Illicit Drug Use ◽  
Final Diagnosis ◽  
T Test ◽  
Psychiatric Unit ◽  
Duration Of Hospitalization

IntroductionIn substance – related disorders comorbidity refers to any preexisting or following psychological or psychiatric condition that influence the course and prognosis of a patient.ObjectivesTo determine the extent of comorbid substance use and psychiatric disorders among hospitalized in a General Hospital Psychiatric Unit patients and reveal the implications of treatment in such a unit.MethodAll patients hospitalized during a year, were included in the study. Demographics, final diagnosis, substance of use and means of admission (voluntary or involuntary) were recorded.Results7.4% of the total of 339 inpatients met the diagnostic criteria of comorbid substance use disorders. Eleven of them were diagnosed with alcohol use disorder comorbidity, 7 with illicit drug use comorbidity and 7 with both legal and illicit drug use comorbidity. Among inpatients with comorbid use disorders male patients had a significantly higher percentage versus females (x2 p < 0.05). Mean age of inpatients with comorbidity was significantly less than the mean age of the sample (t-test p < 0.05). Duration of hospitalization for inpatients with comorbidity was 15.16 ± 12.4 days versus 21.2 ± 18.4 days for the rest of patients (t-test p < 0.05). Concerning the way of admission, 72% of inpatients with comorbid use disorders were involuntary admitted (x2 p < 0.05).ConclusionConcerning age, sex and means of admission patients with a psychiatric disorder and substance use disorder comorbidity seem to vary from the rest of inpatients. These parameters are probably associated with serious difficulties in therapeutic compliance and with increased hazard.

scholarly journals Systematic review of universal school-based resilience interventions targeting adolescent tobacco, alcohol or illicit drug use: review protocol

BMJ Open ◽  
2014 ◽  
Vol 4 (5) ◽  
pp. e004718 ◽  
Author(s):  
Rebecca Kate Hodder ◽  
Megan Freund ◽  
Luke Wolfenden ◽  
Jenny Bowman ◽  
Karen Gillham ◽  
...  
Keyword(s):  
Systematic Review ◽  
Drug Use ◽  
Illicit Drug ◽  
Illicit Drug Use ◽  
School Based ◽  
Review Protocol

scholarly journals Cannabis and Illicit Drug Use During Neurodevelopment and the Associated Structural, Functional and Cognitive Outcomes: Protocol for a Systematic Review (Preprint)

2020 ◽  
Author(s):  
Jennifer Debenham ◽  
Nicola Newton ◽  
Louise Birrell ◽  
Murat Yücel ◽  
Briana Lees ◽  
...  
Keyword(s):  
Systematic Review ◽  
Drug Use ◽  
Illicit Drugs ◽  
Illicit Drug ◽  
Illicit Drug Use ◽  
Cognitive Outcomes ◽  
Medical Subject Headings ◽  
Neuropsychological Development ◽  
Assessment Development ◽  
Meta Analyses

BACKGROUND High rates of cannabis and illicit drug use are experienced by young people during the final stages of neurodevelopment (aged 15-24 years), a period characterized by high neuroplasticity. Frequent drug use during this time may interfere with neurophysiological and neuropsychological development pathways, potentially leading to ongoing unfavorable neuroadaptations. The dose-response relationship between illicit drug use, exposure, and individual neurodevelopmental variation is unknown but salient with global shifts in the legal landscape and increasingly liberal attitudes and perceptions of the harm caused by cannabis and illicit drugs. OBJECTIVE This systematic review aims to synthesize longitudinal studies that investigate the effects of illicit drug use on structural, functional, and cognitive brain domains in individuals under the neural age of adulthood (25 years). This protocol outlines prospective methods that will facilitate an exhaustive review of the literature exploring pre- and post-drug use brain abnormalities arising during neurodevelopment. METHODS Five electronic databases (Medline, Embase, PsycINFO, ProQuest Central, and Web of Science) will be systematically searched between 1990 and 2019. The search terms will be a combination of MeSH (Medical Subject Headings), with keywords adapted to each database. Study reporting will follow the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, and if relevant, study quality will be assessed using the Grades of Recommendation, Assessment, Development, and Evaluation (GRADE) approach. Eligible studies are those that sampled youth exposed to cannabis or illicit drugs and employed neurophysiological or neuropsychological assessment techniques. Studies will be excluded if participants had been clinically diagnosed with any psychiatric, neurological, or pharmacological condition. RESULTS This is an ongoing review. As of February 2020, papers are in full-text screening, with results predicted to be complete by July 2020. CONCLUSIONS Integrating data collected on the three brain domains will enable an assessment of the links between structural, functional, and cognitive brain health across individuals and may support the early detection and prevention of neurodevelopmental harm. CLINICALTRIAL PROSPERO CRD42020151442; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=151442 INTERNATIONAL REGISTERED REPORT PRR1-10.2196/18349

scholarly journals Cannabis and Illicit Drug Use During Neurodevelopment and the Associated Structural, Functional and Cognitive Outcomes: Protocol for a Systematic Review

10.2196/18349 ◽  
2020 ◽  
Vol 9 (7) ◽  
pp. e18349
Author(s):  
Jennifer Debenham ◽  
Nicola Newton ◽  
Louise Birrell ◽  
Murat Yücel ◽  
Briana Lees ◽  
...  
Keyword(s):  
Systematic Review ◽  
Drug Use ◽  
Illicit Drugs ◽  
Illicit Drug ◽  
Illicit Drug Use ◽  
Cognitive Outcomes ◽  
Medical Subject Headings ◽  
Neuropsychological Development ◽  
Assessment Development ◽  
Meta Analyses

Background High rates of cannabis and illicit drug use are experienced by young people during the final stages of neurodevelopment (aged 15-24 years), a period characterized by high neuroplasticity. Frequent drug use during this time may interfere with neurophysiological and neuropsychological development pathways, potentially leading to ongoing unfavorable neuroadaptations. The dose-response relationship between illicit drug use, exposure, and individual neurodevelopmental variation is unknown but salient with global shifts in the legal landscape and increasingly liberal attitudes and perceptions of the harm caused by cannabis and illicit drugs. Objective This systematic review aims to synthesize longitudinal studies that investigate the effects of illicit drug use on structural, functional, and cognitive brain domains in individuals under the neural age of adulthood (25 years). This protocol outlines prospective methods that will facilitate an exhaustive review of the literature exploring pre- and post-drug use brain abnormalities arising during neurodevelopment. Methods Five electronic databases (Medline, Embase, PsycINFO, ProQuest Central, and Web of Science) will be systematically searched between 1990 and 2019. The search terms will be a combination of MeSH (Medical Subject Headings), with keywords adapted to each database. Study reporting will follow the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, and if relevant, study quality will be assessed using the Grades of Recommendation, Assessment, Development, and Evaluation (GRADE) approach. Eligible studies are those that sampled youth exposed to cannabis or illicit drugs and employed neurophysiological or neuropsychological assessment techniques. Studies will be excluded if participants had been clinically diagnosed with any psychiatric, neurological, or pharmacological condition. Results This is an ongoing review. As of February 2020, papers are in full-text screening, with results predicted to be complete by July 2020. Conclusions Integrating data collected on the three brain domains will enable an assessment of the links between structural, functional, and cognitive brain health across individuals and may support the early detection and prevention of neurodevelopmental harm. Trial Registration PROSPERO CRD42020151442; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=151442 International Registered Report Identifier (IRRID) PRR1-10.2196/18349

scholarly journals Systematic review of surveillance by social media platforms for illicit drug use

2017 ◽  
Vol 39 (4) ◽  
pp. 763-776 ◽  
Author(s):  
Donna M Kazemi ◽  
Brian Borsari ◽  
Maureen J Levine ◽  
Beau Dooley
Keyword(s):  
Systematic Review ◽  
Social Media ◽  
Drug Use ◽  
Illicit Drug ◽  
Illicit Drug Use ◽  
Social Media Platforms
Sign in / Sign up

Export Citation Format

Share Document